« Previous | Contents | Next »
Listen
CANCER IN SCOTLAND: ACTION FOR CHANGE
08. SUPPORTING RESEARCH AND DEVELOPMENT
"Research remains necessary in all areas of cancer prevention, detection and diagnosis as well as into its causes and treatment. It is only through such research that we will continue steadily to improve outcomes for people with cancer."
Treatment and Care: Clinical Trials
The research community provided feedback on a range of issues aiming to boost cancer research in Scotland (particularly relating to trials) in February 2002.
An additional 1 million is available to support a Scottish Cancer Clinical Trials Network which will enable cancer networks to develop the infrastructure required to at least double patient recruitment into clinical trials. The Scottish Network, which it is hoped will be established by the end of 2002, will be part of the UK National Cancer Trials Network (NCRN) and UK National Cancer Research Institute (NCRI).
What the Scottish Executive is Doing
The Chief Scientist Office (CSO) is currently formally consulting for suggestions to shape its future priorities in greater detail. As part of this exercise CSO is establishing focus groups that are being invited to provide more detailed guidance. For cancer this is already fairly well developed.
Genetics and Cancer
The Genetics Sub Group of the Scottish Cancer Group continue to maintain a watching brief on developments in the genetics field. As a result of the continuing developments in Medical Genetics, partly from the Human Genome Project, new genetic explanations for certain forms of cancer predisposition are regularly identified. Where these have significant implications for the management of families in Scotland, new guidance will be incorporated into the current arrangements.
« Previous | Contents | Next »